Shalini C Reshmi, PhD :: Nationwide Children's Hospital, Columbus, Ohio
Shalini C Reshmi menu

e-newsletters

Sign up for Health e-Hints our FREE customized health informaion parent enewsletter Sign up for Peds Online our Free Medical Professional Enewsletter

stay connected

 

live referral help

Click here to speak with a hospital representative.

Shalini C Reshmi, PhD

Shalini C Reshmi, PhD

Clinical Pathology
Director, Institute for Genomic Medicine Clinical Laboratory

Pathology and Laboratory Medicine
Clinical Pathology Team

Pathology Fellowship
Faculty

Contact Information

Laboratory Medicine/ Anatomic Pathology
700 Children's Dr.
Columbus, OH 43205 [ map ]
PH: (614) 722-5779
FX: (614) 722-5471
Email Me

Biography

Dr. Reshmi received her doctoral degree from the University of Pittsburgh, Graduate School of Public Health. She completed her Clinical Genetics fellowships at the University of Chicago, Pritzker School of Medicine. She is board certified in both Clinical Cytogenetics and Clinical Molecular Genetics. Her areas of responsibility at Nationwide Children's Hospital include the Clinical Cytogenetics and Molecular Genetics laboratories and the Nationwide Children's Oncology Group (COG) reference laboratories for Acute Lymphoblastic Leukemia, Neuroblastoma, and Wilms Tumor. She is also a Assistant Professor (Clinical) of Pathology at The Ohio State University.

View CV »

Gender:

  • Female

Languages Spoken:

  • English

Education and Training

Undergraduate School

  • The Catholic University of America
    Date Completed: 05/30/1992

Graduate School

  • University of Pittsburgh
    Date Completed: 05/30/1996

Graduate School

  • University of Pittsburgh
    Date Completed: 05/30/2005

Fellowship

  • University of Chicago
    Date Completed: 11/30/2008

Section:

  • Clinical Pathology

Date of Appointment at Nationwide Children’s Hospital:

  • 12/01/2008

Professional Experience

2008–present

  • Assistant Professor,(Clinical)Pathology, The Ohio State University

2008–present

  • Assistant Director of the Cytogenetics and Molecular Genetics Laboratories, Nationwide Children's Hospital, Department of Laboratory Medicine

2008–present

  • Assistant Director of the Children's Oncology Group Reference Laboratory, The Research Institute at Nationwide Children's Hospital

2005–2008

  • Clinical Cytogenetics and Molecular Genetics Fellow

2001–2005

  • Graduate Student Researcher, Cancer Cytogenetics; The University of Pittsburgh

2001–2001

  • Supervisor, Cytogenetics Facility; University of Pittsburgh Cancer Institute and Center for Human Genetics and Integrative Biology

1999–2001

  • Cytogenetic Technologist, Allegheny General Hospital

Publications

  • 2016. Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia.  NATURE COMMUNICATIONS. Vol. 7, no. November 8.
  • Gu Z, Churchman M, Roberts K, Li Y, Liu Y, Harvey RC, McCastlain K, Reshmi SC, Payne-Turner D, Iacobucci I, Shao Y, Chen I-M, Valentine M, Pei D, Mungall KL, Mungall AJ, Ma Y, Moore R, Marra M, Stonerock E, Gastier-Foster JM, Devidas M, Dai Y, Wood B, Borowitz M, Larsen EE, Maloney K, Mattano LA, Angiolillo A, Salzer WL, Burke MJ, Gianni F, Spinelli O, Radich JP, Minden MD, Moorman AV, Patel B, Fielding AK, Rowe JM, Luger SM, Bhatia R, Aldoss I, Forman SJ, Kohlschmidt J, Mrózek K, Marcucci G, Bloomfield CD, Stock W, Kornblau S, Kantarjian HM, Konopleva M, Paietta E, Willman CL, Loh M, Hunger S, Mullighan CG. 2016. Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia.  NATURE COMMUNICATIONS. Vol. 7, no. November: e13331.
  • Iacobucci I, Li Y, Roberts KG, Dobson SM, Kim JC, Payne-Turner D, Harvey RC, Valentine M, McCastlain K, Easton J, Yergeau D, Janke LJ, Shao Y, Chen I-Ming L, Rusch M, Zandi S, Kornblau SM, Konopleva M, Jabbour E, Paietta EM, Rowe JM, Pui C-H, Gastier-Foster J, Gu Z, Reshmi S, Loh ML, Racevskis J, Tallman MS, Wiernik PH, Litzow MR, Willman CL, McPherson JD, Downing JR, Zhang J, Dick JE, Hunger SP, Mullighan CG. 2016. Truncating erythropoietin receptor rearrangements in acute lymphoblastic leukemia.  CANCER CELL. Vol. 29, no. 2. (February): 186-200.
  • 2016. Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia.  Cancer cell. Vol. 29, no. 2. (February 1).
  • Walters-Sen LC, Hashimoto S, Thrush DL, Reshmi S, Gastier-Foster JM, Astbury Caroline, Pyatt RE. 2015. Variability in pathogenicity prediction programs: impact on clinical diagnostics.  MOLECULAR GENETICS AND GENOMIC MEDICINE. Vol. 3, no. 2. (March): 99-110.
  • Walters-Sen LC, Hashimoto S, Thrush DL, Reshmi S, Gastier-Foster JM, Astbury C, Pyatt RE. 2015. Variability in pathogenicity prediction programs: impact on clinical diagnostics.  Molecular Genetics and Genomics medicine. Vol. 2, no. March 1: 99-110-99-110.
  • 2014. Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia.  NEW ENGLAND JOURNAL OF MEDICINE. Vol. 371, no. 11. (September 11).
  • Roberts KG, Li Y, Payne-Turner D, Harvey RC, Yang Y-L, Pei D, McCastlain K, Ding L, Lu C, Song G, Ma J, Becksfort J, Rusch M, Chen S-C, Easton J, Cheng J, Boggs K, Santiago-Morales N, Iacobucci I, Fulton RS, Wen J, Valentine M, Cheng C, Paugh SW, Devidas M, Chen I-M, Reshmi S, Smith A, Hedlund E, Gupta P, Nagahawatte P, Wu G, Chen X, Yergeau D, Vadodaria B, Mulder H, Winick NJ, Larsen EC, Carroll WL, Heerema NA, Carroll AJ, Grayson G, Tasian SK, Moore AS, Keller F, Frei-Jones M, Whitlock JA, Raetz EA, White DL, Hughes TP, Auvil JMG, Smith MA, Marcucci G, Bloomfield CD, Mrozek K, Kohlschmidt J, Stock W, Kornblau SM, Konopleva M, Paietta E, Pui C-H, Jeaha S, Relling MV, Evans WE, Gerhard DS, Gastier-Foster JM, Mardis E, Wilson RK, Loh ML, Downing JR, Hunger SP, Willman CL, Zhang J, Mullighan CG. 2014. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.  NEW ENGLAND JOURNAL OF MEDICINE. Vol. 371, no. 11. (September): 1005-1015.
  • Walters-Sen LC, Thrush DL, Hickey SE, Hashimoto S, Reshmi S, Gastier-Foster JM, Pyatt RE, Astbury C. 2014. Atypical breakpoint in a t(6;17) translocation case of acampomelic campomelic dysplasia.  EUROPEAN JOURNAL OF MEDICAL GENETICS. Vol. 57, no. 7. (July): 315-318.
  • 2014. Atypical breakpoint in a t(6;17) translocation case of acampomelic campomelic dysplasia.  EUROPEAN JOURNAL OF MEDICAL GENETICS. Vol. 57, no. 7. (July 1).
  • Polan MB, Pastore MT, Steingass K, Hashimoto S, Thrush DL, Pyatt R, Reshmi S, Gastier-Foster JM, Astbury C, McBride KL. 2014. Neurodevelopmental disorders among individuals with duplication of 4p13 to 4p12 containing a GABA(A) receptor subunit gene cluster.  EUROPEAN JOURNAL OF HUMAN GENETICS. Vol. 22, no. 1. (January 1): 105-109-105-109.
  • Polan MB, Pastore MT, Steingass K, Hashimoto S, Thrush DL, Pyatt R, Reshmi S, Gastier-Foster JM, Astbury C, McBride KL. 2014. Neurodevelopmental disorders among individuals with duplication of 4p13 to 4p12 containing a GABA(A) receptor subunit gene cluster.  EUROPEAN JOURNAL OF HUMAN GENETICS. Vol. 22, no. 1. (January): 105-109.
  • Repnikova,Elena,A; Rosenfeld,Jill,A; Bailes,Andrea; Weber,Cecilia; Erdman,Linda; McKinney,Aimee; Ramsey,Sarah; Hashimoto,Sayaka; Lamb Thrush,Devon; Astbury,Caroline; Reshmi,Shalini,C; Shaffer,Lisa,G; Gastier-Foster,Julie,M; Pyatt,Robert,E. 2013. Characterization of copy number variation in genomic regions containing STR loci using array comparative genomic hybridization.  Forensic science international. Genetics. Vol. 7, no. 5. (September): 475-481.
  • Repnikova EA, Rosenfeld JA, Bailes A, Weber C, Erdman L, McKinney A, Ramsey S, Hashimoto S, Thrush DL, Astbury C, Reshmi SC, Shaffer LG, Gastier-Foster JM, Pyatt RE. 2013. Characterization of copy number variation in genomic regions containing STR loci using array comparative genomic hybridization.  FORENSIC SCIENCE INTERNATIONAL-GENETICS. Vol. 7, no. 5. (September 1): 475-481-475-481.
  • Hickey SE, Thrush DL, Walters-Sen L, Reshmi SC, Astbury C, Gastier-Foster JM, Atkin J. 2013. A case of an atypically large proximal 15q deletion as cause for Prader-Willi syndrome arising from a de novo unbalanced translocation.  EUROPEAN JOURNAL OF MEDICAL GENETICS. Vol. 56, no. 9. (September 1): 510-514-510-514.
  • Repnikova EA, Rosenfeld JA, Bailes A, Weber C, Erdman L, McKinney A, Ramsey S, Hashimoto S, Thrush DL, Astbury C, Reshmi SC, Shaffer LG, Gastier-Foster JM, Pyatt RE. 2013. Characterization of copy number variation in genomic regions containing STR loci using array comparative genomic hybridization.  FORENSIC SCIENCE INTERNATIONAL-GENETICS. Vol. 7, no. 5. (September): 475-481.
  • Hickey SE, Thrush DL, Walters-Sen L, Reshmi SC, Astbury C, Gastier-Foster JM, Atkin J. 2013. A case of an atypically large proximal 15q deletion as cause for Prader-Willi syndrome arising from a de novo unbalanced translocation.  EUROPEAN JOURNAL OF MEDICAL GENETICS. Vol. 56, no. 9. (September): 510-514.
  • Rosales XQ, Malik V, Sneh A, Chen L, Lewis S, Kota J, Gastier-Foster JM, Astbury C, Pyatt R, Reshmi S, Rodino-Klapac LR, Clark KR, Mendell JR, Sahenk Z. 2013. Impaired regeneration in LGMD2A supported by increased PAX7-positive satellite cell content and muscle-specific microrna dysregulation.  MUSCLE & NERVE. Vol. 47, no. 5. (May): 731-739.
  • Rosales XQ, Malik V, Sneh A, Chen L, Lewis S, Kota J, Gastier-Foster JM, Astbury C, Pyatt R, Reshmi S, Rodino-Klapac LR, Clark KR, Mendell JR, Sahenk Z. 2013. Impaired regeneration in LGMD2A supported by increased PAX7-positive satellite cell content and muscle-specific microrna dysregulation.  MUSCLE & NERVE. Vol. 47, no. 5. (May 1): 731-739-731-739.
  • Alyaqoub F, Pyatt RE, Bailes A, Brock A, Deeg C, McKinney A, Astbury C, Reshmi S, Shane KP, Thrush DL, Sommer A, Gastier-Foster JM. 2012. 12q14 microdeletion associated with HMGA2 gene disruption and growth restriction.  AMERICAN JOURNAL OF MEDICAL GENETICS PART A. Vol. 158A, no. 11. (November 1): 2925-2930-2925-2930.
  • Alyaqoub F, Pyatt RE, Bailes A, Brock A, Deeg C, McKinney A, Astbury C, Reshmi S, Shane KP, Thrush DL, Sommer A, Gastier-Foster JM. 2012. 12q14 microdeletion associated with HMGA2 gene disruption and growth restriction.  AMERICAN JOURNAL OF MEDICAL GENETICS PART A. Vol. 158A, no. 11. (November): 2925-2930.
  • Repnikova EA, Astbury C, Reshmi SC, Ramsey SN, Atkin JF, Thrush DL, Mitchell AL, Pyatt RE, Reber K, Slavin T, Gastier-Foster JM. 2012. Microarray comparative genomic hybridization and cytogenetic characterization of tissue-specific mosaicism in three patients.  AMERICAN JOURNAL OF MEDICAL GENETICS PART A. Vol. 158A, no. 8. (August): 1924-1933.
  • Repnikova EA, Astbury C, Reshmi SC, Ramsey SN, Atkin JF, Thrush DL, Mitchell AL, Pyatt RE, Reber K, Slavin T, Gastier-Foster JM. 2012. Microarray comparative genomic hybridization and cytogenetic characterization of tissue-specific mosaicism in three patients.  AMERICAN JOURNAL OF MEDICAL GENETICS PART A. Vol. 158A, no. 8. (August 1): 1924-1933-1924-1933.
  • 2012. Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study.  Blood. Vol. 119, no. 15. (April 12).
  • Chen,I,Ming; Harvey,Richard,C; Mullighan,Charles,G; Gastier-Foster,Julie; Wharton,Walker; Kang,Huining; Borowitz,Michael,J; Camitta,Bruce,M; Carroll,Andrew,J; Devidas,Meenakshi; Pullen,D,Jeanette; Payne-Turner,Debbie; Taisan,Sarah,K; Reshmi,Shalini; Cottrell,Catherine,E; Reaman,Gregory,H; Bowman,W,Paul; Carroll,William,L; Loh,Mignon,L; Winick,Naomi,J; Hunger,Stephen,P; Willman,Cheryl,L. 2012. Outcome modeling with CRLF2, IKZF1, JAK and minimal residual disease Study in pediatric acute lymphoblastic leukemia: a Children's Oncology Group.  BLOOD. Vol. 119, no. 15. (April): 3512-3522.
  • Chen IM, Harvey RC, Mullighan CG, Gastier-Foster J, Wharton W, Kang H, Borowitz MJ, Camitta BM, Carroll AJ, Devidas M, Pullen DJ, Payne-Turner D, Tasian SK, Reshmi S, Cottrell CE, Reaman GH, Bowman WP, Carroll WL, Loh ML, Winick NJ, Hunger SP, Willman CL. 2012. Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group Study.  BLOOD. Vol. 119, no. 15. (April): 3512-3522.
  • Chen IM, Harvey RC, Mullighan CG, Gastier-Foster J, Wharton W, Kang H, Borowitz MJ, Camitta BM, Carroll AJ, Devidas M, Pullen DJ, Payne-Turner D, Taisan SK, Reshmi S, Cottrell CE, Reaman GH, Bowman WP, Carroll WL, Loh ML, Winick NJ, Hunger SP, Willman CL. 2012. Outcome modeling with CRLF2, IKZF1, JAK and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group Study.  BLOOD. Vol. 119, no. 15. (April): 3512-3522.
  • 2011. Evidence of a mechanism for isodicentric chromosome Y formation in a 45,X/46,X,idic(Y)(p11.31)/46,X,del(Y)(p11.31) mosaic karyotype.  EUROPEAN JOURNAL OF MEDICAL GENETICS. Vol. 54, no. 2. (March 1).
  • Reshmi SC, Miller JL, Deplewski D, Close C, Henderson LJ, Littlejohn E, Schwartz S, Waggoner DJ. 2011. Evidence of a mechanism for isodicentric chromosome Y formation in a 45,X/46,X,idic(Y)(p11.31)/46,X,del(Y)(p11.31) mosaic karyotype.  EUROPEAN JOURNAL OF MEDICAL GENETICS. Vol. 54, no. 2. (March): 161-164.
  • Reshmi SC, Miller JL, Deplewski D, Close C, Henderson LJ, Littlejohn E, Schwartz S, Waggoner DJ. 2011. Evidence of a mechanism for isodicentric chromosome Y formation in a 45,X/46,X,idic(Y)(p11.31)/46,X,del(Y)(p11.31) mosaic karyotype.  EUROPEAN JOURNAL OF MEDICAL GENETICS. Vol. 54, no. 2. (March): e161.
  • Cottrell CE, Prior TW, Pyatt R, Astbury C, Reshmi S, Bartholomew D, Atkin J, Manickam K, Thrush DL, Pastore M, Mendell J, Tsao CY, Al-Dahhak R, Newmeyer A, Gastier-Foster JM. 2010. Unexpected detection of dystrophin gene deletions by array comparative genomic hybridization.  AMERICAN JOURNAL OF MEDICAL GENETICS PART A. Vol. 152A, no. 9. (September 1): 2301-2307-2301-2307.
  • Cottrell CE, Prior TW, Pyatt R, Astbury C, Reshmi S, Bartholomew D, Atkin J, Manickam K, Thrush DL, Pastore M, Mendell J, Tsao CY, Al-Dahhak R, Newmeyer A, Gastier-Foster JM. 2010. Unexpected detection of dystrophin gene deletions by array comparative genomic hybridization.  AMERICAN JOURNAL OF MEDICAL GENETICS PART A. Vol. 152A, no. 9. (September): 2301-2307.
  • Rosales XQ, Gastier-Foster JM, Lewis S, Malik V, Thrush DL, Astbury C, Pyatt R, Reshmi S, Sahenk Z, Mendell JR. 2010. Novel diagnostic features of dysferlinopathies.  MUSCLE & NERVE. Vol. 42, no. 1. (July): 14-21.
  • Rosales XQ, Gastier-Foster JM, Lewis S, Malik V, Thrush DL, Astbury C, Pyatt R, Reshmi S, Sahenk Z, Mendell JR. 2010. Novel diagnostic features of dysferlinopathies.  MUSCLE & NERVE. Vol. 42, no. 1. (July 1): 14-21-14-21.
  • 2010. Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia.  CHEMICO-BIOLOGICAL INTERACTIONS. Vol. 184, no. 1-2. (March 19).
  • Qian Z; Joslin JM; Tennant TR; Reshmi SC; Young DJ; Stoddart A; Larson RA; Le Beau MM. 2010. Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia.  Chemico-Biological Interactions. Vol. 184, no. 1-2. (March): e50.
  • Qian Z, Joslin JM, Tennant TR, Reshmi SC, Young DJ, Stoddart A, Larson RA, Le Beau MM. 2010. Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia.  CHEMICO-BIOLOGICAL INTERACTIONS. Vol. 184, no. 1-2. (March): 50-57.
  • Cottrell CE, Prior TW, Pyatt R, Astbury C, Reshmi SC, Bartholomew D, Atkin J, Lamb-Thrush D, Pastore M, Mendell J, Tsao C-Y, Al-Dahhak R, Newmeyer A, and Gastier-Foster JM. 2010. Incidental Detection of Dystrophin Gene Deletions by Array Comparative Genomic Hybridization.  Am J Med Genet A. Vol. 152A, no. January: 2301-7.
  • Rosales XQ, Gastier-Foster JM, Lewis S, Vinod M, Thrush DL, Astbury C, Pyatt R, Reshmi S, Sahenk Z, Mendell JR. 2010. Novel diagnostic features of dysferlinopathies.  Muscle & Nerve. Vol. 42, no. January: 14-21.
  • Cottrell CE, Prior TW, Pyatt R, Astbury C, Reshmi SC, Bartholomew D, Atkin J, Lamb-Thrush D, Pastore M, Mendell J, Tsao C-Y, Al-Dahhak R, Newmeyer A, and Gastier-Foster JM. 2010. Incidental Detection of Dystrophin Gene Deletions by Array Comparative Genomic Hybridization.  Am J Med Genet A. Vol. 152A, no. January 1: 2301-7-2301-7.
  • Martin CL, Reshmi SC, Ried T, Gottberg W, Wilson JW, Reddy JK, Khanna P, Johnson JT, Myers EN, Gollin SM. 2008. Chromosomal imbalances in oral squamous cell carcinoma: Examination of 31 cell lines and review of the literature.  ORAL ONCOLOGY. Vol. 44, no. 4. (April): 369-382.
  • 2008. Chromosomal imbalances in oral squamous cell carcinoma: Examination of 31 cell lines and review of the literature.  ORAL ONCOLOGY. Vol. 44, no. 4. (April 1).
  • Martin CL; Reshmi SC; Ried T; Gottberg W; Wilson JW; Reddy JK; Khanna P; Johnson JT; Myers EN; Gollin SM. 2008. Chromosomal imbalances in oral squamous cell carcinoma: examination of 31 cell lines and review of the literature.  Oral Oncology. Vol. 44, no. 4. (April): e369.
  • Reshmi SC, Huang X, Schoppy DW, Black RC, Saunders WS, Smith DI, Gollin SM. 2007. Relationship between FRA11F and 11q13 gene amplification in oral cancer.  GENES CHROMOSOMES & CANCER. Vol. 46, no. 2. (February): 143-154.
  • Reshmi SC; Huang X; Schoppy DW; Black RC; Saunders WS; Smith DI; Gollin SM. 2007. Relationship between FRA11F and 11q13 gene amplification in oral cancer.  Genes, Chromosomes & Cancer. Vol. 46, no. 2. (February): e143.
  • 2007. Relationship between FRA11F and 11q13 gene amplification in oral cancer.  GENES CHROMOSOMES & CANCER. Vol. 46, no. 2. (February 1).
  • Reshmi SC, Roychoudhury S, Yu Z, Feingold E, Potter D, Saunders WS, Gollin SM. 2007. Inverted duplication pattern in anaphase bridges confirms the breakage-fusion-bridge (BFB) cycle model for 11q13 amplification.  CYTOGENETIC AND GENOME RESEARCH. Vol. 116, no. 1-2. (January): 46-52.
  • 2007. Inverted duplication pattern in anaphase bridges confirms the breakage-fusion-bridge (BFB) cycle model for 11q13 amplification.  CYTOGENETIC AND GENOME RESEARCH. Vol. 116, no. 1-2. (January 1).
  • Reshmi SC, Roychaudhry S, Yu Z, Feingold E, Potter D, Saunders WS, Gollin SM. 2007. Inverted duplication pattern in anaphase bridges confirms the breakage-fusion-bridge (BFB) cycle model for 11q13 amplification.  Cytogenet Genome Res. Vol. 116, no. January: 46-52.
  • Wittschieben JP, Reshmi SC, Gollin SM, Wood RD. 2006. Loss of DNA polymerase zeta causes chromosomal instability in mammalian cells.  CANCER RESEARCH. Vol. 66, no. 1. (January): 134-142.
  • 2006. Loss of DNA polymerase zeta causes chromosomal instability in mammalian cells.  CANCER RESEARCH. Vol. 66, no. 1. (January 1).
  • Wittschieben JP; Reshmi SC; Gollin SM; Wood RD. 2006. Loss of DNA polymerase zeta causes chromosomal instability in mammalian cells.  Cancer Research. Vol. 66, no. 1. (January): e134.
  • Cook JR, Aguilera NI, Reshmi S, Huang X, Yu ZS, Gollin SM, Abbondanzo SL, Swerdlow SH. 2005. Deletion 6q is not a characteristic marker of nodal lymphoplasmacytic lymphoma.  CANCER GENETICS AND CYTOGENETICS. Vol. 162, no. 1. (October 1): 85-88-85-88.
  • Cook JR, Aguilera NI, Reshmi S, Huang X, Yu ZS, Gollin SM, Abbondanzo SL, Swerdlow SH. 2005. Deletion 6q is not a characteristic marker of nodal lymphoplasmacytic lymphoma.  CANCER GENETICS AND CYTOGENETICS. Vol. 162, no. 1. (October): 85-88.
  • 2005. Chromosomal instability in oral cancer cells.  JOURNAL OF DENTAL RESEARCH. Vol. 84, no. 2. (February 1).
  • Reshmi SC; Gollin SM. 2005. Chromosomal instability in oral cancer cells.  Journal Of Dental Research. Vol. 84, no. 2. (February): e107.
  • Reshmi SC, Gollin SM. 2005. Chromosomal instability in oral cancer cells.  JOURNAL OF DENTAL RESEARCH. Vol. 84, no. 2. (February): 107-117.
  • Cook J, Aguilera N, Reshmi S, Huang X, Yu Z, Gollin S, Abbondanzo S, Swerdlow S. 2005. Deletion 6q is not a characteristic marker of nodal lymphoplasmacytic lymphoma.  Cancer Genet Cytogenet. Vol. 162, no. January: 85-88.
  • Reshmi SC; Saunders WS; Kudla DM; Ragin CR; Gollin SM. 2004. Chromosomal instability and marker chromosome evolution in oral squamous cell carcinoma.  Genes, Chromosomes & Cancer. Vol. 41, no. 1. (September): e38.
  • 2004. Chromosomal instability and marker chromosome evolution in oral squamous cell carcinoma.  GENES CHROMOSOMES & CANCER. Vol. 41, no. 1. (September 1).
  • Reshmi SC, Saunders WS, Kudla DM, Ragin CR, Gollin SM. 2004. Chromosomal instability and marker chromosome evolution in oral squamous cell carcinoma.  GENES CHROMOSOMES & CANCER. Vol. 41, no. 1. (September): 38-46.
  • 2004. Mapping and analysis of HPV16 integration sites in a head and neck cancer cell line.  INTERNATIONAL JOURNAL OF CANCER. Vol. 110, no. 5. (July 10).
  • Ragin CC; Reshmi SC; Gollin SM. 2004. Mapping and analysis of HPV16 integration sites in a head and neck cancer cell line.  International Journal Of Cancer. Journal International Du Cancer. Vol. 110, no. 5. (July): e701.
  • Ragin CR, Reshmi SC, Gollin SM. 2004. Mapping and analysis of HPV16 integration sites in a head and neck cancer cell line.  INTERNATIONAL JOURNAL OF CANCER. Vol. 110, no. 5. (July): 701-709.
  • Cook JR, Aguilera NI, Reshmi-Skarja SC, Huang X, Yu ZS, Gollin SM, Abbondanzo SL, Swerdlow SH. 2004. Lack of PAX5 rearrangements in lymphoplasmacytic lymphomas: Reassessing the reported association with t(9;14).  HUMAN PATHOLOGY. Vol. 35, no. 4. (April): 447-454.
  • Cook JR, Aguilera NI, Reshmi-Skarja SC, Huang X, Yu ZS, Gollin SM, Abbondanzo SL, Swerdlow SH. 2004. Lack of PAX5 rearrangements in lymphoplasmacytic lymphomas: Reassessing the reported association with t(9;14).  HUMAN PATHOLOGY. Vol. 35, no. 4. (April 1): 447-454-447-454.
  • Cook JR, Aguilera NI, Reshmi-Skarja S, Huang X, Yu Z, Gollin SM, Abbondanzo SL, and Swerdlow SH. 2004. Lack of PAX5 Rearrangements in lymphoplasmacytic lymphomas: reassessing the reported association with t(9;14).  Hum Pathol. Vol. 35, no. January: 1-8.
  • 2003. Chromosomal fragility in patients with triple A syndrome.  American journal of medical genetics. Part A. Vol. 117A, no. 1. (February 1).
  • Reshmi-Skarja S, Huebner A, Handschug K, Finegold DN, Clark AL, Gollin SM. 2003. Chromosomal fragility in patients with triple A syndrome.  AMERICAN JOURNAL OF MEDICAL GENETICS PART A. Vol. 117A, no. 1. (February): 30-36.
  • Cook JR, Aguilera NI, Reshmi-Skarja SC, Gollin SM, Huang X, Abbondanzo SL, Swerdlow SH. 2003. Absence of PAX5 rearrangements in lymphoplasmacytic lymphomas by interphase FISH.  MODERN PATHOLOGY. Vol. 16, no. 1. (January): 229A-229A.
  • Reshmi Skarja S, Huebner A, Handschug K, Finegold DN, Clark AJL and Gollin SM. 2003. Chromosomal fragility in patients with triple A syndrome.  Am J Med Genet. Vol. 117A, no. January: 30-36.
  • Cook JR, Aguilera NI, Reshmi-Skarja SC, Gollin SM, Huang X, Abbondanzo SL, Swerdlow SH. 2003. Absence of PAX5 rearrangements in lymphoplasmacytic lymphomas by interphase FISH.  LABORATORY INVESTIGATION. Vol. 83, no. 1. (January 1): 229A-229A-229A-229A.
  • Cook JR, Aguilera NI, Reshmi-Skarja SC, Gollin SM, Huang X, Abbondanzo SL, Swerdlow SH. 2003. Absence of PAX5 rearrangements in lymphoplasmacytic lymphomas by interphase FISH.  LABORATORY INVESTIGATION. Vol. 83, no. 1. (January): 229A-229A.
  • Cook JR, Aguilera NI, Reshmi-Skarja SC, Gollin SM, Huang X, Abbondanzo SL, Swerdlow SH. 2003. Absence of PAX5 rearrangements in lymphoplasmacytic lymphomas by interphase FISH.  MODERN PATHOLOGY. Vol. 16, no. 1. (January 1): 229A-229A-229A-229A.
  • Martinez-Climent JA, Comes AM, Vizcarra E, Reshmi S, Benet I, Marugan I, Tormo M, Terol MJ, Solano C, Arbona C, Prosper F, Barragan E, Bolufer P, Rowley JD, Garcia-Conde J. 1999. Variant three-way translocation of inversion 16 in AML-M4Eo confirmed by fluorescence in situ hybridization analysis.  CANCER GENETICS AND CYTOGENETICS. Vol. 110, no. 2. (April): 111-114.
  • Martinez-Climent JA, Comes AM, Vizcarra E, Reshmi S, Benet I, Marugan I, Tormo M, Terol MJ, Solano C, Arbona C, Prosper F, Barragan E, Bolufer P, Rowley JD, Garcia-Conde J. 1999. Variant three-way translocation of inversion 16 in AML-M4Eo confirmed by fluorescence in situ hybridization analysis.  CANCER GENETICS AND CYTOGENETICS. Vol. 110, no. 2. (April 1): 111-114-111-114.
  • Rowley JD, Reshmi S, Carlson K, Roulston D. 1999. Spectral karyotype analysis of T-cell acute leukemia.  BLOOD. Vol. 93, no. 6. (March 1): 2038-2042-2038-2042.
  • Rowley JD, Reshmi S, Carlson K, Roulston D. 1999. Spectral karyotype analysis of T-cell acute leukemia.  BLOOD. Vol. 93, no. 6. (March): 2038-2042.
  • Fleischman EW, Reshmi S, Frenkel MA, Konovalova WI, Guleva GP, Kulagina OE, Konstantinova LN, Tupitsyn NN, Rowley JD. 1999. MLL is involved in a t(2;11)(p21;q23) in a patient with acute myeloblastic leukemia.  GENES CHROMOSOMES & CANCER. Vol. 24, no. 2. (February 1): 151-155-151-155.
  • Fleischman EW, Reshmi S, Frenkel MA, Konovalova WI, Guleva GP, Kulagina OE, Konstantinova LN, Tupitsyn NN, Rowley JD. 1999. MLL is involved in a t(2;11)(p21;q23) in a patient with acute myeloblastic leukemia.  GENES CHROMOSOMES & CANCER. Vol. 24, no. 2. (February): 151-155.
  • Rowley JD, Reshmi S, Carlson K and Roulston D. 1999. Spectral karyotype analysis of T-cell acute leukemia.  Blood. Vol. 93, no. January: 2038-2042.
  • Fleischman EW, Reshmi S, Sokova OI, Kirichenko OP, Konstantinova LN, Kulagina OE, Frenkel MA and Rowley JD. 1999. Increased karyotype precision using fluorescence in situ hybridization and spectral karyotyping in patients with myeloid malignancies.  Cancer Genet Cytogenet. Vol. 108, no. January: 166-170.
  • Fleischman EW, Reshmi S, Frenkel MA, Konovalova WI, Guleva GP, Kulagina OE, Konstantinova LN, Tupitsyn NN and Rowley JD. 1999. MLL is involved in a t(2;11)(p21;q23) in a patient with acute myeloblastic leukemia.  Genes Chromosomes Cancer. Vol. 24, no. January: 151-155.
  • Fleischman EW, Reshmi S, Sokova OI, Kirichenko OP, Konstantinova LN, Kulagina OE, Frenkel MA, Rowley JD. 1999. Increased karyotype precision using fluorescence in situ hybridization and spectral karyotyping in patients with myeloid malignancies.  CANCER GENETICS AND CYTOGENETICS. Vol. 108, no. 2. (January): 166-170.
  • Fleischman EW, Reshmi S, Sokova OI, Kirichenko OP, Konstantinova LN, Kulagina OE, Frenkel MA, Rowley JD. 1999. Increased karyotype precision using fluorescence in situ hybridization and spectral karyotyping in patients with myeloid malignancies.  CANCER GENETICS AND CYTOGENETICS. Vol. 108, no. 2. (January 1): 166-170-166-170.
  • Martinez-Climent JA, Comes AM, Vizcarra E, Reshmi S, Benet I, Marugan I, Tormo M, Terol MJ, Solano C, Arbona C, Prosper F, Barragan E, Bolufer P, Rowley JD and Garcia-Conde J. 1999. Variant three-way translocation of inversion 16 in AML-M4Eo confirmed by fluorescence in situ hybridization analysis.  Cancer Genet Cytogenet. Vol. 100, no. January: 111-114.
  • 1997. Heterogeneity in the breakpoints in balanced rearrangements involving band 12p13 in hematologic malignancies identified by fluorescence in situ hybridization: TEL (ETV6) is involved in only one half.  Blood. Vol. 90, no. 12. (December 15).
  • Sato Y, Bohlander SK, Kobayashi H, Reshmi S, Suto Y, Davis EM,Espinosa R, Hoopes R, Montgomery KT, Kucherlapati RS, Lebeau MM, Rowley JD. 1997. Heterogeneity in the breakpoints in balanced rearrangements involving band 12p13 in hematologic malignancies identified by fluorescence in situ hybridization: TEL (ETV6) is involved in only one half.  BLOOD. Vol. 90, no. 12. (December): 4886-4893.
  • 1997. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia.  Genes, chromosomes & cancer. Vol. 20, no. 2. (October 1).
  • Super HG; Strissel PL; Sobulo OM; Burian D; Reshmi SC; Roe B; Zeleznik-Le NJ; Diaz MO; Rowley JD. 1997. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia.  Genes, Chromosomes & Cancer. Vol. 20, no. 2. (October): e185.
  • Super HG, Strissel PL, Sobulo OM, Burian D, Reshmi SC, Roe B, Zeleznikle NJ, Diaz MO, Rowley JD. 1997. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia.  GENES CHROMOSOMES & CANCER. Vol. 20, no. 2. (October): 185-195.
  • Sobulo OM, Borrow J, Tomek R, Reshmi S, Harden A, Schlegelberger B, Housman D, Doggett NA, Rowley JD, Zeleznikle NJ. 1997. MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3).  PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. Vol. 94, no. 16. (August 1): 8732-8737-8732-8737.
  • Sobulo OM, Borrow J, Tomek R, Reshmi S, Harden A, Schlegelberger B, Housman D, Doggett NA, Rowley JD, Zeleznikle NJ. 1997. MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3).  PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. Vol. 94, no. 16. (August): 8732-8737.
  • Rowley JD, Reshmi S, Sobulo O, Musvee T, Anastasi J, Raimondi S, Schneider NR, Barredo JC, Cantu ES, Schlegelberger B, Behm F, Doggett NA, Borrow J, Zeleznikle N. 1997. All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders.  BLOOD. Vol. 90, no. 2. (July): 535-541.
  • Rowley JD, Reshmi S, Sobulo O, Musvee T, Anastasi J, Raimondi S, Schneider NR, Barredo JC, Cantu ES, Schlegelberger B, Behm F, Doggett NA, Borrow J, Zeleznikle N. 1997. All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders.  BLOOD. Vol. 90, no. 2. (July 1): 535-541-535-541.
  • Sato Y, Bohlander SK, Kobayashi H, Reshmi S, Suto Y, Davis EM, Espinosa III R, Hoopes R, Montgomery KT, Kucherlapati RS, Le Beau MM and Rowley JD. 1997. Heterogeneity In the breakpoints in balanced rearrangements involving band 12p13 in hematologic malignancies identified by fluorescence in situ hybridization: TEL(ETV6) is involved in only one half.  Blood. Vol. 90, no. January: 4886-4893.
  • Rowley JD, Reshmi S, Sobulo T, Musvee T, Anastasi J, Raimondi S, Schneider NR, Barredo JC, Cantu ES, Schlegelberger B, Behm F, Doggett NA, Burrow J and Zeleznik-Le N. 1997. All patients with the t(11;16)(q23;p13.3) that involve MLL and CBP have treatment- Related hematologic disorders.  Blood. Vol. 90, no. January: 535-541.
  • Rowley JD, Reshmi S, Sobulo T, Musvee T, Anastasi J, Raimondi S, Schneider NR, Barredo JC, Cantu ES, Schlegelberger B, Behm F, Doggett NA, Burrow J and Zeleznik-Le N. 1997. All patients with the t(11;16)(q23;p13.3) that involve MLL and CBP have treatment- Related hematologic disorders.  Blood. Vol. 90, no. January 1: 535-541-535-541.
  • Sobulo OM, Burrow J, Tomek R, Reshmi S, Harden A, Schlegelberger B, Housman D, Doggett NA, Rowley JD and Zeleznik-Le NJ. 1997. MLL is fused to CBP, a histone acetyltransferase, in therapy related acute myeloid leukemia with a t(11;16)(q23;p13.3).  Proc Natl Acad Sci USA. Vol. 94, no. January: 8732-8737.
  • Rathod PK, Reshmi S. 1994. Susceptibility of plasmodium-falciparum to a combination of thymidine and ICI D1694, A quinazoline antifolate directed at thymidylate synthase.  ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. Vol. 38, no. 3. (March 1): 476-480-476-480.
  • Rathod PK, Reshmi S. 1994. Susceptibility of plasmodium-falciparum to a combination of thymidine and ICI D1694, A quinazoline antifolate directed at thymidylate synthase.  ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. Vol. 38, no. 3. (March): 476-480.
  • Rathod PK and Reshmi S. 1994. Susceptibility of Plasmodium falciparum to a combination of thymidine and ICI D1694, a quinazoline antifolate directed at thymidylate synthase.  Antimicrob Agents Chemother. Vol. 38, no. January: 476-480.

Awards, Honors and Organizations

  • Invited participant, 3rd Annual St. Jude National Graduate Student Symposium, St. Jude Children's Research Hospital, Memphis, TN, 2004
  • American Society of Human Genetics, Member, 1994 - Present
  • Public Health Dean's Scholarship Recipient, Outstanding Doctoral Student, University of Pittsburgh, 2004
  • Children's Oncology Group, Member, 2008 - Present
  • Certified Molecular Pathology and Cytogenetics CAP Inspector, 2011 - Present
  • Association for Molecular Pathology, Member, 2008 - Present
  • American College of Medical Genetics, Member, 2007 - Present
  • Best doctoral dissertation, Human Genetics, Delta Omega National Honor Society, Omicron Chapter Pittsburgh, PA, 2005
Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000